# Humacyte, Inc.: Form 8-K, filed Aug 25, 2021

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2021-08-25
- Accepted by EDGAR: Aug 25, 2021, 10:11 ET
- Period: 2021-08-24
- Accession: 0001213900-21-044669
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000121390021044669/ea146398-8k_alphahealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000121390021044669/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000121390021044669/ea146398-8k_alphahealth.htm

Filed Aug 25, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-044669. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.